Dossier
de-extinction startup
Coverage of de-extinction startup in the Nexus archive.
- Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Colossal Biosciences, a de-extinction startup, is reportedly in talks to raise new capital with a valuation range of $20B–$30B, aiming to double or triple its previous valuation.